Napredna pretraga

Pregled bibliografske jedinice broj: 629646

Phospholipids and Alzheimer’s disease: alterations, mechanisms and potential biomarkers


Košiček, Marko; Hećimović, Silva
Phospholipids and Alzheimer’s disease: alterations, mechanisms and potential biomarkers // International journal of molecular sciences, 14 (2013), 1; 1310-1322 doi:10.3390/ijms14011310 (međunarodna recenzija, pregledni rad, znanstveni)


Naslov
Phospholipids and Alzheimer’s disease: alterations, mechanisms and potential biomarkers

Autori
Košiček, Marko ; Hećimović, Silva

Izvornik
International journal of molecular sciences (1422-0067) 14 (2013), 1; 1310-1322

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni

Ključne riječi
Phospholipid; Alzheimer’s disease; biomarker

Sažetak
Brain is one of the richest organs in lipid content. Phospholipids (glycerophospholipids and sphingolipids) are important building blocks of cell membranes, which provide an optimal environment for protein interactions, trafficking and function. Because of that, alterations in their cellular levels could lead to different pathogenic processes in the brain, such as in Alzheimer's disease (AD), the most common type of dementia among older populations. There is increasing evidence that phospholipid changes occur during pathogenic processes in AD. It is known that lipids are tightly connected with metabolism of the Amyloid Precursor Protein (APP), which produces Amyloid-beta peptide (Aβ), the main component of senile plaques, which represent the main pathological hallmark of AD. However, the mechanism(s) of the lipid-effect on Aβ metabolism and AD pathogenesis is still not completely understood. This review summarizes the current knowledge on phospholipid changes occurring during normal aging and discusses phospholipid changes in the human brain associated with different stages of AD, as well changes in the cerebrospinal fluid and blood/plasma, which are interesting potential biomarkers for AD diagnosis and disease monitoring. At the end, we have discussed future perspectives of phospholipid changes as potential biomarkers and as targets for development of novel treatment strategies against AD.

Izvorni jezik
Engleski



POVEZANOST RADA


Citiraj ovu publikaciju

Košiček, Marko; Hećimović, Silva
Phospholipids and Alzheimer’s disease: alterations, mechanisms and potential biomarkers // International journal of molecular sciences, 14 (2013), 1; 1310-1322 doi:10.3390/ijms14011310 (međunarodna recenzija, pregledni rad, znanstveni)
Košiček, M. & Hećimović, S. (2013) Phospholipids and Alzheimer’s disease: alterations, mechanisms and potential biomarkers. International journal of molecular sciences, 14 (1), 1310-1322 doi:10.3390/ijms14011310.
@article{article, year = {2013}, pages = {1310-1322}, DOI = {10.3390/ijms14011310}, keywords = {phospholipid, Alzheimer’s disease, biomarker}, journal = {International journal of molecular sciences}, doi = {10.3390/ijms14011310}, volume = {14}, number = {1}, issn = {1422-0067}, title = {Phospholipids and Alzheimer’s disease: alterations, mechanisms and potential biomarkers}, keyword = {phospholipid, Alzheimer’s disease, biomarker} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati